Noninvasive vagus nerve stimulation for prevention and treatment of primary headaches in children and teens
Official title: Noninvasive Vagus Nerve Stimulation for the Prevention and Treatment of Primary Headache: a Single-arm Single-center Clinical Trial.
Run by Nanfang Hospital, Southern Medical University · NCT06277063 · Data updated 2026-11-12
We will try a noninvasive ear-based vagus nerve stimulator to treat sudden primary headache attacks in children and adolescents aged 7–20.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 7 Years to 20 Years |
| Sex | All |
| Enrollment | 15 (estimated) |
| Sponsor | Nanfang Hospital, Southern Medical University Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Status | Recruiting |
| Started | December 5, 2024 |
| Main results expected | August 31, 2026 |
| Study ends | December 30, 2026 |
| Registry record updated | August 12, 2025 |
| Trial ID | NCT06277063 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children and adolescents 7–20 years old with diagnosed primary headaches (migraine, cluster, or tension-type) who experience 3–15 headache days per month and keep medications stable are ideal candidates.
✕Probably not a fit
Patients with secondary headaches, a history of seizures, implanted electronic devices, or those unable to attend in-person visits are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center, single-arm study enrolls participants aged 7–20 with primary headaches and applies transcutaneous auricular vagus nerve stimulation (nVNS) during acute exacerbations. Each subject receives the same short-duration stimulation with the electrode placed on the concha and stimulation intensity adjusted individually. Headache scores before and after the intervention will be compared to measure acute symptom change, and concurrent ECG and EMG data will be collected to develop objective response markers. Participants must have 3–15 headache days per month and maintain stable medication regimens during the study.
Why it matters
Potential benefit: If successful, the device could offer a quick, non-drug option to reduce the intensity of acute headache attacks in children and adolescents.
How similar studies have gone: Similar nVNS approaches have shown promising but mixed results for acute migraine and cluster headache in adults, while pediatric evidence is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients with migraine, cluster headache and tension-type headache were diagnosed according to Chinese Guidelines for the diagnosis and Treatment of Migraine (2022 edition) and Chinese Guidelines for the diagnosis and treatment of cluster headache (2022 edition). 2. Age \>=7 years old, \<=20 years old; 3. Patients have experienced headache on 3-15 days per month in the past; 4. Maintain a stable dose and frequency of medication and do not take new drugs during the course of participating in the trial; 5. They volunteered to participate in the trial and signed informed consent. Exclusion Criteria: 1. History of secondary headache, aneurysm, intracranial hemorrhage, brain tumor, severe head trauma, drug abuse, addiction, syncope, or seizures; 2. prior migraine-preventive surgery, cervical vagotomy, or implantation of an electronic or neurostimulator device; 3. Simultaneous use of other devices (e.g., TENS devices, muscle stimulators); 4. An implantable medical device in use, such as a pacemaker, hearing aid, or any implantable electronic device; 5. underwent head and neck nerve block within the past 2 months; 6. Opioid use (more than 2 days per month); Use of analgesics alone or non-steroidal anti-inflammatory drugs (more than 15 days per month); Or tamoxifen, ergots or combination analgesics (more than 10 days per month); 7. Patients who underwent cervical vagotomy (cervical vagotomy); 8. Pediatric patients (under 6 years old); Pregnant women; 9. Patients with clinically significant hypertension, hypotension, bradycardia or tachycardia; 10. Patients with congenital heart disease; 11. Mental/cognitive disorders, etc.
Where it's running
-
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, China Recruiting
Study contacts
- Principal investigator: Ji Ya-Bin, post-doc — Nanfang Hospital, Southern Medical University
- Study coordinator: Xiao XueZhen, PhD
- Email: xuezhenxiao@brainclos.com
- Phone: +8613425122570
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
A real-world look at trigeminal autonomic cephalalgias in Italy
This study follows adults with TACs like cluster headache and related conditions in routine care to see how treatments work and what factors influence outcomes over time.
-
Magnesium sulfate for acute non-traumatic headache in the ED: 2 g vs 4 g vs standard paracetamol
This study tests whether intravenous magnesium sulfate given in different doses helps adults with acute non-traumatic headache in the emergency department, compared with paracetamol.
-
Mindfulness vs Headache Education for Teens with Migraine
This study tests whether a teen-friendly mindfulness program delivered by telehealth helps adolescents with migraine as compared with a headache education program.
-
Using light therapy to treat chronic cluster headaches
This study is testing whether light therapy using a special device can help people with chronic cluster headaches feel better.
-
Understanding how the brain processes chronic pain in children
This study is trying to understand how children's brains handle chronic pain from conditions like migraines and fibromyalgia to see what helps them recover.
-
Transcranial Direct Current Stimulation for Long COVID with Headaches and Chronic Pain
This study tests whether applying mild brain stimulation (tDCS) can help people with long COVID who have headaches, migraines, and ongoing pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.